Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Medtronic
QuintilesIMS
Accenture
Federal Trade Commission
Argus Health
Baxter
Merck
Cipla

Generated: July 17, 2018

DrugPatentWatch Database Preview

Altretamine - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for altretamine and what is the scope of altretamine freedom to operate?

Altretamine
is the generic ingredient in one branded drug marketed by Eisai Inc and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for altretamine. One supplier is listed for this compound.
Pharmacology for altretamine
Drug ClassAlkylating Drug
Mechanism of ActionAlkylating Activity
Medical Subject Heading (MeSH) Categories for altretamine
Synonyms for altretamine
[4,6-bis(dimethylamino)(1,3,5-triazin-2-yl)]dimethylamine
1,3,5-Triazine-2,4,6-triamine, N,N,N',N',N',N'-hexamethyl-
1,3,5-Triazine-2,4,6-triamine, N,N,N',N',N'', N''-hexamethyl-
1,3,5-Triazine-2,4,6-triamine, N,N,N',N',N'',N''-hexamethyl-
1,5-Triazine-2,4,6-triamine, N,N,N',N',N'',N''-hexamethyl-
2-N,2-N,4-N,4-N,6-N,6-N-hexamethyl-1,3,5-triazine-2,4,6-triamine
2,4, 6-Tris(dimethylamino)-1,3,5-triazine
2,4,6-Tris(dimethylami
2,4,6-Tris(dimethylamino-s-triazine
2,4,6-Tris(dimethylamino)-1,3,5-triazine
2,4,6-Tris(dimethylamino)-1,3,5-triazine, 96%
2,4,6-Tris(dimethylamino)-s-triazine
2,6-Tris(dimethylamino)-1,3,5-triazine
2,6-Tris(dimethylamino)-s-triazine
3B1-006990
49712-EP2295426A1
49712-EP2295427A1
49712-EP2308833A2
49712-EP2311825A1
645-05-6
645-05-6,2975-00-0(HCl)
645A056
A 8723
A0567/0026158
A834788
AB00052308
AB00052308_19
AB00052308_20
AB00052308-16
AB00052308-17
AB00052308-18
AB0007992
AB2000024
ABP000596
AC-12006
AC1L1CYX
AI3-50852
AK431828
AKOS001729401
Altretamin
Altretamina
Altretamina [INN-Spanish]
Altretamine (Hexalen)
Altretamine (USP/INN)
Altretamine [2,4,6-Tris(dimethylamino)-1,3,5-triazine]
Altretamine [USAN:INN:BAN]
Altretamine Bellon Brand
Altretamine Chiesi Brand
Altretamine Wassermann Brand
Altretamine, solid
Altretamine, United States Pharmacopeia (USP) Reference Standard
Altretamine/
Altretaminum
Altretaminum [INN-Latin]
AN-47064
BC203873
BCP9000278
BCPP000413
BDBM37631
Bellon Brand of Altretamine
BPBio1_001004
BRD-K67043667-001-04-1
BRN 0195058
BSPBio_000912
C9H18N6
Cambridge id 5148727
CAS-645-05-6
CAS-654-05-6
CCG-2238
CCRIS 5492
CHEBI:24564
CHEMBL1455
ChemDiv2_005185
Chiesi Brand of Altretamine
cid_2123
CPD000058181
CS-2061
CTK8F7682
D02841
D02LPF
DB00488
DivK1c_000772
DR000364
DSSTox_CID_2579
DSSTox_GSID_22579
DSSTox_RID_76641
DTXSID4022579
EINECS 211-428-4
ENT 50852
EU-0100083
FT-0083576
FT-0651499
GTPL7112
HE372371
Hemel
Hexalen
Hexalen (TN)
Hexalen, Altretamine
HEXAMETHYLMELAMINE
Hexastat
Hexinawas
hexylen
HMM
HMS1383L15
HMS1570N14
HMS1922C05
HMS2090G17
HMS2092H16
HMS2097N14
HMS2234F09
HMS3259I20
HMS3260A08
HMS3372H17
HMS3654H11
HMS502G14
HSDB 7559
HTM
HXM
HY-B0181
I06-0604
IDI1_000772
IDI1_003900
InChI=1/C9H18N6/c1-13(2)7-10-8(14(3)4)12-9(11-7)15(5)6/h1-6H
J-523408
KB-913
KBio1_000772
KBio2_001788
KBio2_004356
KBio2_006924
KBio3_002042
KBioGR_001388
KBioSS_001788
KS-00001F6N
KS-5247
Lopac-A-8723
Lopac0_000083
LP00083
LS-1549
M-2093
MCULE-1605383293
Melamine, hexamethyl-
MGI Pharma Brand of Altretamine
MLS000069621
MLS001076123
MolPort-002-111-210
N-[4,6-bis(dimethylamino)-1,3,5-triazin-2-yl]-N,N-dimethylamine
N,N,N',N',N'',N''-hexamethyl-1,3,5-triazine-2,4,6-triamine
N~2~,N~2~,N~4~,N~4~,N~6~,N~6~-Hexamethyl-1,3,5-triazine-2,4,6-triamine
N2,N2,N4,N4,N6,N6-Hexamethyl-1,3,5-trazne-2,4,6-tramne
N2,N2,N4,N4,N6,N6-hexamethyl-1,3,5-triazine-2,4,6-triamine
NC 195
NC00595
NCGC00015100-01
NCGC00015100-02
NCGC00015100-03
NCGC00015100-04
NCGC00015100-05
NCGC00015100-06
NCGC00015100-07
NCGC00015100-08
NCGC00015100-09
NCGC00015100-10
NCGC00015100-11
NCGC00015100-12
NCGC00015100-14
NCGC00015100-15
NCGC00021216-03
NCGC00021216-04
NCGC00021216-05
NCGC00021216-06
NCGC00021216-07
NCGC00260330-01
NCGC00260768-01
NCI-C50259
NCI60_000871
NINDS_000772
No-s-triazine
NSC 13875
NSC-13875
NSC-758231
NSC13875
NSC758231
Opera_ID_1095
Pharmakon1600-01503065
Prestwick0_000946
Prestwick1_000946
Prestwick2_000946
Prestwick3_000946
Q8BIH59O7H
Rhone Poulenc Rorer Brand of Altretamine
Rhone-Poulenc Rorer Brand of Altretamine
RP18094
s-Triazine, 2,4,6-tris(dimethylamino)-
s-Triazine,4,6-tris(dimethylamino)-
s1278
SAM002564241
SBI-0050071.P003
SC-26614
SCHEMBL4206
SMR000058181
SPBio_000754
SPBio_003071
Spectrum_001308
SPECTRUM1503065
Spectrum2_000907
Spectrum3_000951
Spectrum4_001064
Spectrum5_001092
SR-01000000117
SR-01000000117-2
ST086739
STK749184
Tox21_110085
Tox21_110085_1
Tox21_202784
Tox21_500083
UNII-Q8BIH59O7H
UUVWYPNAQBNQJQ-UHFFFAOYSA-N
VA10242
Wassermann Brand of Altretamine
WLN: T6N CN ENJ BN1&1 DN1&1 FN1&1
Z57931197
ZB000200
ZINC905

US Patents and Regulatory Information for altretamine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Eisai Inc HEXALEN altretamine CAPSULE;ORAL 019926-001 Dec 26, 1990 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
US Army
AstraZeneca
Citi
Cipla
Johnson and Johnson
Argus Health
Harvard Business School
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.